title: Autoimmune bullous diseases in Austria.
abstract: Autoimmune bullous diseases (AIBD) are chronic disorders associated with significant morbidity and even mortality, for which the 19 dermatologic departments in Austria apply standard modalities to provide state-of-the-art diagnosis and treatment. Most of the affected individuals are initially treated on an inpatient basis, with follow-up done in specialized outpatient clinics or in private practices. A well-established system of care for AIBD patients is thus available nationwide. Considering the significant morbidity and mortality but also rareness of AIBD, national and international standardization of AIBD administration in registries is a major requirement of further improvement in patient care.
authors.affiliation: Department of Dermatology, Paracelsus Medical University Salzburg, Muellner Hauptstrasse 48, A-5020 Salzburg, Austria. m.laimer@salk.at
authors.forename: Martin
authors.initials: M
authors.lastname: Laimer
authors.forename: Gabriela
authors.initials: G
authors.lastname: Pohla-Gubo
authors.forename: Lukas
authors.initials: L
authors.lastname: Kraus
authors.forename: Elke
authors.initials: E
authors.lastname: Nischler
authors.forename: J W
authors.initials: JW
authors.lastname: Bauer
authors.forename: V
authors.initials: V
authors.lastname: Ahlgrimm-Siess
authors.forename: Helmut
authors.initials: H
authors.lastname: Hintner
mesh_terms: D001317:Austria / Q000453:epidemiology; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D003695:Delivery of Health Care / Q000458:organization & administration; D003879:Dermatologic Agents / Q000627:therapeutic use; D003880:Dermatology / Q000458:organization & administration; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D012042:Registries / Q000706:statistics & numerical data; D012872:Skin Diseases, Vesiculobullous / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*
chemical_list: D003879:Dermatologic Agents; D007166:Immunosuppressive Agents